<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">983</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2020-9-18-20</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The market is driven by the public sector</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kalinina</surname><given-names>Nadezhda</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">RM Analytics</aff><pub-date date-type="epub" iso-8601-date="2020-12-09" publication-format="electronic"><day>09</day><month>12</month><year>2020</year></pub-date><issue>9</issue><fpage>18</fpage><lpage>20</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>The public sector has been actively growing over the past two years and is still a growth driver for the entire pharmaceutical market. The unfavourable epidemiological situation and government investments in the sector have given a boost to the Russian pharmaceutical market in the first months of this year. The public sector reached the level of RUB 301 bil. at purchase prices for the period from January to June 2020. According to the estimates of most analytical agencies, the sector will continue to grow in the second half of the year, though its growth will slow down slightly.</abstract><kwd-group xml:lang="en"><kwd>Russian Federation’s pharmaceutical market</kwd><kwd>public segment</kwd><kwd>public sector</kwd><kwd>public procurement</kwd><kwd>TN rating</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фармацевтический рынок РФ</kwd><kwd>государственный сегмент</kwd><kwd>госсектор</kwd><kwd>госзакупки</kwd><kwd>рейтинг ТН</kwd></kwd-group></article-meta></front><body></body><back/></article>
